Sulfur Containing Reactant Patents (Class 530/404)
  • Patent number: 4668584
    Abstract: A method is provided for forming ordered macromolecular protein arrays by avoiding a binding pathway that leads to densely packed, disordered states during protein crystal growth, by a diffusion limited process or by allowing controlled growth to occur by removal of the initial supported protein layer to a different environment.
    Type: Grant
    Filed: December 23, 1985
    Date of Patent: May 26, 1987
    Assignee: General Electric Company
    Inventors: Egidijus E. Uzgiris, James R. Yates
  • Patent number: 4661347
    Abstract: A cytotoxic composition is described comprising a moiety having binding affinity to a surface structure of a cell and coupled to a moiety having activity as a structural subunit of C3/C5 convertase.
    Type: Grant
    Filed: March 7, 1985
    Date of Patent: April 28, 1987
    Assignee: Scripps Clinic
    Inventors: Hans J. Muller-Eberhard, Carl-Wilhelm E. Vogel
  • Patent number: 4659569
    Abstract: The present invention relates to a process for the production of virus vaccine, comprising covalently attaching virus to saccharide to form a virus-saccharide conjugate, and harvesting the resultant conjugate. The virus vaccine, prepared according to the present invention, exhibits a higher producibility of immunoglobulin G and immunoglobulin M antibodies, while it induces less or substantially no production of immunoglobulin E antibody, in comparison with conventional-type inactivated virus vaccine; thus, the present vaccine is favorably usable for the prevention and treatment of viral diseases.
    Type: Grant
    Filed: January 4, 1982
    Date of Patent: April 21, 1987
    Assignee: Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo
    Inventors: Masakazu Mitsuhashi, Shunsaku Koyama
  • Patent number: 4647655
    Abstract: There is described a method for splitting at least one disulphide bond --S--S--, where each of the sulphur atoms is directly bound covalently to its respective aliphatic carbon atom in an organic substance which contains at least one such disulphide bond, in which each bond --S--S-- which is split is converted substantially to two reactive groups of the formulae --S--S--R.sub.1 and R.sub.2 --S--S--, where R.sub.1 and R.sub.2 are equal or different and each is an organic residue. Splitting of the bond is effected by reacting said organic substance with a mixture of a compound R.sub.3 --S--S--R.sub.4 and a compound capable of existing in the tautomeric forms R.sub.5 --S--H and HR.sub.5 .dbd.S or corresponding resonance-stabilized anion forms, in which compounds the residues R.sub.3, R.sub.4 and R.sub.5 (i) are organic residues of which all are different, two are equal or all are equal, and (ii) are defined in (a) that each of the aforesaid sulphur atoms in the compounds R.sub.3 --S--S--R.sub. 4 and R.sub.
    Type: Grant
    Filed: January 16, 1985
    Date of Patent: March 3, 1987
    Assignee: Pharmacia Aktiebolag
    Inventors: Rolf E. Axen, Jan P. Carlsson, Hakan N. Drevin
  • Patent number: 4612283
    Abstract: A method for purification of HBs antigen, which comprises treating an HBs tigen-containing material with an acid, optionally subjecting to salting out with ammonium sulfate, and subjecting the material to a chromatography with hydroxyapatite, by which a highly purified HBs antigen suitable for the preparation of HBV vaccine or diagnostic agent can be obtained in an industrial scale. This method is particularly useful for the purification of HBs antigen-containing material produced by recombinants obtained by DNA recombination technique.
    Type: Grant
    Filed: October 1, 1984
    Date of Patent: September 16, 1986
    Assignee: 501 Juridical Foundation, The Chemo-Sero-Therapeutic Research Institute
    Inventors: Keishin Sugahara, Chikateru Nozaki, Fukusaburo Hamada, Fumio Miake, Nobuya Ohtomo